Amiodarone;Amiodaron

Intensivmedizin und Notfallmedizin

Volumn 38, Issue 3, 2001, Pages 169-178

  Trappe, Hans Joachim ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Amiodarone; Cardiac arrest; Sudden death; Ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; FLECAINIDE; PHENYTOIN; PLACEBO; PROCAINAMIDE; WARFARIN;

ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PHOTOSENSITIVITY DISORDER; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 0035032720     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900170080     Document Type: Article

References (56)

1. Adams PC, Holt DW, Storey CA, Morley AR, Callaghan J, Campbell WF (1985) Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 72: 1064-1075
2. Anderson NE, Lynch NM, O'Brien KP (1985) Disabling neurological complications of amiodarone. Aus NZ J Med 15:300-304
3. Burkhart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 16:1711-1718
4. Cobb LA, Hallstrom AP (1982) Community-based cardiopulmonary resuscitation: what have we learned? Ann NY Acad Sci 382:330-342
5. Conolly SJ (1999) Evidence-based analysis of amiodarone efficacy and safety. Circulation 100:2025-2034
6. Dusman RE, Stanton MS, Miles WM, Klein LS, Zipes DP, Fineberg NS, Heger J (1990) Clinical features of amiodaron-induced pulmonary toxicity. Circulation 82:51-59
7. Faber TS, Zehender M, Van-de-Loo A, Hohnloser S, Just H (1994) Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. Clin Cardiol 17:197-202
8. Fatovich DM, Prentice DA, Dobb GJ (1997) Magnesium in cardiac arrest: the magic trial. Resuscitation 35:237-241
9. Figa FH, Gow RM, Hamilton RM, Freedom RM (1994) Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol 74:573-577
10. Fornaciari G, Monducci I, Barone A, Bacci C, Beltrami M, Tomasi C (1992) Amiodarone-induced acute hepatitis. J Clin Gastroenterol 15:271-273
11. Gillum RF (11989) Sudden coronary death in the United States 1989-1985. Circulation 79:756-765
12. Greene HL, for the CASCADE Investigators (1993) The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol 72:70F-74F
13. Hamer A, Peter T, Mandel WJ, Scheinman MM, Weiss D (1982) The potentiation of warfarin anticoagulation by amiodarone. Circulation 65: 1025-1029
14. Harris L, McKenna WJ, Rowland E, Krikler DM (1983) Side effects and possible contraindications and amiodarone use. Am Heart J 106:916-923
15. Heger JJ, Prystowsky EN, Zipes DP (1983) Relationships between amiodarone dosage, drug concentration, and adverse side effects. Am Heart J 106:931-935
16. Herlitz J, Ekstrom L, Wennerblom B (1997) Lidocaine in out-of-hospital ventricular fibrillation: does it improve survival? Resuscitation 33:199-205
17. Hohnloser S, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. Ann Intern Med 121:529-535
18. Holt DW, Tucker GT, Jackson PR, Storey GCA (1983) Amiodarone pharmacocinetics. Am Heart J 106:840-846
19. Jung W, Lüderitz B (1998) Empfehlungen für die präklinische Notfallmedizin. Akuttherapie tachykarder Herzrhythmusstörungen. Internist 39:142-151
20. Khand AU, Rankin AC, Kaye GC, Cleland JGF (2000) Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21:614-632
21. Killian SY, Geyman JP, Gossom JB, Girnlett D (1996) Out-of-hospital cardiac arrest in a rural area. A 16 year experience with lessons learned and national comparisond. Ann Emerg Med 28:294-300
22. Kosinski EJ, Albin JB, Young E, Lewis SM, LeLand S Jr (1984) Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 4:565-570
23. Kowey PR, Marinchak RA, Rials SJ, Filart RA (1997) Intravenous amiodarone. J Am Coll Cardiol 29:1190-1198
24. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341:871-878
25. Larsen M, Eisenberg M, Cumins R, Hallstrom A (1994) Predicting survival from out-of- hospital cardiac arrest - a graphic model. Ann Emerg Med 22:1652-1658
26. Lombardi G, Gallgher EJ, Gennis P (1994) Outcome of out-of-hospital cardiac arrest in New York City. The prehospital arrest survival evaluation (phase) study. JAMA 271:678-683
27. Marcus FI (1983) Drug interactions with amiodarone. Am Heart J 106:924-929
28. Mason JW (1987) Amiodarone. N Engl J Med 316:455-466
29. Olson DW, Thompson BM, Darin JC, Milbrath MH (1984) A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 13:807-810
30. Pfisterer ME, Kiowski W, Brunner H, Burckhardt D, Burkart F (1993) Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 87:309-311
31. Pichler WJ, Schindler L, Staubli M, Stadler BM, de Week AL (1988) Anti-amiodarone antibodies: detection and relationship to the development of side effects. Am J Med 85:197-202
32. Raeder EA, Podrid PJ, Lown B (1985) Side effects and complications of amiodarone therapy. Am Heart J 109:975-983
33. Roden DM, Woosley RL, Primm RK (1986) Incidence and clinical features of the quinidine- associated long QT syndrome: implications for patient care. Am Heart J 111:1088-1096
34. Rosenbaum MB, Chiale PA, Ryba D, Elizari MV (1974) Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 34:215-223
35. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV (1976) Clinical efficacy as an antiarrhythmic agent. Am J Cardiol 38:934-944
36. Rosenbaum MB, Chiale PA, Haedo A, Lazzari JO, Elizari MV (1983) Ten years of experience with amiodarone. Am Heart J 106:957-964
37. Rothenberg F, Franklin JO, DeMaio SJ (1994) Use, value and toxicity of amiodarone. Heart-Dis-Stroke 3:19-23
38. Sedgwick ML, Dalziel K, Watson J, Carrington DJ, Cobbe SM (1994) The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project. Resuscitation 27:55-59
39. Singh BN, Vaughan Williams EM (1970) The effect of amiodaron, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657-667
40. Singh BN, Nademanee K (1983) Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. Am Heart J 106:857-868
41. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333:77-82
42. Soyka LF, Wirtz C, Spangenberg RB (1990) Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 65:74A-81A
43. Späth G (1992) Herzrhythmusstörungen. Aktuelle Bedeutung von Amiodaron. Belz, Weinheim, S 244-327
44. Storch WH (2000) Das Konzept der Frühdefibrillation. In: Arntz HR, Schuster HP (Hrsg) Die Notfalltherapie bei akutem Myokardinfarkt. Steinkopff, Darmstadt, S 47-53
45. Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM (1997) Randomised trial of magnesium in in-hospital cardiac arrest. Lancet 350:1272-1276
46. Trappe HJ (1996) Amiodaron und Nebenwirkungen. In: Madea B, Winter UJ, Schwonzen M, Radermacher R (Hrsg) Innere Medizin und Recht. Blackwell Wissenschafts-Verlag, Berlin, S 284-296
47. Trappe HJ, Meine M, Pfitzner P, Voigt B, Weismüller P (2001) Aktuelle Aspekte der Defibrillatortherapie bei Herzinsuffizienz. Z Kardiol (im Druck)
48. Trappe HJ (1999) Tachykarde Herzrhythmusstörungen in der Intensivmedizin. In: Zerkowski HR, Baumann G (Hrsg) HerzAkutMedizin. Steinkopff, Darmstadt, S 383-396
49. Trappe HJ (2001) Herzrhythmusstörungen. In: Burchardi H, Larsen R, Schuster HP, Suter PM (Hrsg) Intensivmedizin. Springer, Berlin, Heidelberg, New York, S 657-673
50. Trappe HJ (2000) Diagnosis and treatment of tachycardias. In: Vincent JL (Hrsg) 2000 Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, S 638-648
51. Trappe HJ, Rodriguez LM, Smeets JLRM, Weismüller P (2000) Diagnostik und Therapie von Tachykardien mit schmalem QRS-Komplex. Intensivmed 37:631-643
52. Trappe HJ, Rodriguez LM, Smeets JLRM, Pfitzner P (2000) Diagnostik und Therapie von Tachykardien mit breitem QRS-Komplex. Intensivmed 37:724-735
53. Trappe HJ, Klein H, Lichtlen PR (1992) Ursachen des akuten Herz-Kreislauf-Stillstandes. Internist 33:289-294
54. Velebit V, Podrid P, Lombardi F, Lown B (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65:886-894
55. Waxmann HL, Groh WC, Marchlinski FE, Buxton AE, Sadowski LM, Horowitz LN, Josephson ME (1987) Amiodarone for control of sustained ventricular tachyarrhythmias: clinical and electrophysiologic effects in 51 patients. Am J Cardiol 50:1066-1074
56. Wilson JS, Podrid PJ (1991) Side effects from amiodarone. Am Heart J 121:158-171